4D Molecular Therapeutics
FDMT
#8721
Rank
โ‚ฌ0.11 B
Marketcap
2,38ย โ‚ฌ
Share price
-1.70%
Change (1 day)
-91.02%
Change (1 year)

EPS for 4D Molecular Therapeutics (FDMT)

EPS in 2023 (TTM): -3,10ย โ‚ฌ

According to 4D Molecular Therapeutics's latest financial reports the company's current EPS (TTM) is -3,00ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -3,04ย โ‚ฌ a decrease over its 2021 EPS that were of -2,34ย โ‚ฌ.

EPS history for 4D Molecular Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-3,10ย โ‚ฌ2.12%
2022-3,04ย โ‚ฌ29.69%
2021-2,34ย โ‚ฌ-15.82%
2020-2,78ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,99ย โ‚ฌ-33.54%๐Ÿ‡บ๐Ÿ‡ธ USA